Lexicon Pharmaceuticals (LXRX) Stock Highlights

1.64 | +1.23%

2024-09-19 04:08:13

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of pharmaceutical products for the treatment of human disease. Some of its drugs candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Statistics

Range Today

1.6 1.72

Volume Today 2.84M

Range 1 Year

0.92 3.73

Volume 1 Year 802.09M

Range 3 Year

0.92 6.33

Volume 3 Year 1.32B

Range 10 Year

0.92 19.62

Volume 10 Year 3.53B

Highlights

Market Capitalization 614.54M (small)

Floating Shares 182.14M

Current Price 1.64

Price To Earnings -2.18

Price To Revenue 112.67

Price To Book 2.56

Earnings Per Share -0.78

Payout Ratio 0%

Performance

Latest +1.23%

1 Month -2.38%

3 Months -4.65%

6 Months -36.19%

1 Year +18.84%

3 Years -65.03%

5 Years -47.1%

10 Years -83.84%

Benchmarks

Market Capitalization

156 / 368

Gross Profits

200 / 278

Total Revenue

250 / 300

Total Rank

329 / 368

Free Cashflow

261 / 352

Performance 5 years

165 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.